A new patient-derived iPSC model for dystroglycanopathies validates a compound that increases glycosylation of a-dystroglycan. (2019)
Attributed to:
University College London - Equipment Account
funded by
EPSRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.15252/embr.201947967
PubMed Identifier: 31566294
Publication URI: http://europepmc.org/abstract/MED/31566294
Type: Journal Article/Review
Volume: 20
Parent Publication: EMBO reports
Issue: 11
ISSN: 1469-221X